Personal Liberty Digest™ will be upgraded this weekend to reflect a dynamic new look and mobile-friendly viewing to enhance your experience! Plus, we'll be providing even more of the compelling content you've come to expect, delivered in a whole new way!

  Comments Subscribe to Personal Liberty News Feed Subscribe to Personal Liberty

‘Super’ Aspirin Could Combat Cancers

NEW YORK, March 9 (UPI) — A “super” aspirin may provide extremely strong anti-cancer properties without the side-effect risk of serious stomach ulcers, U.S. researchers say.

Laboratory studies using mice suggest the compound, known as NOSH aspirin, could be effective against cancers of the colon, lung, breast, prostate, pancreas and blood, they said.

“The key components of this new compound are that it is very, very potent and yet it has minimal toxicity to the cells,” researcher Khosrow Kashfi of The City College of New York said.

The compound was seen to shrink human colon cancer tumors implanted in mice by 85 percent “without adverse affects,” he said.

A number of studies have indicated long-term low-dose (75mg a day) aspirin use can reduce the chance of developing certain cancers by up to half, but aspirin can cause serious stomach ulcers in some people, particularly the elderly.

The U.S. researchers have been working to develop a form of aspirin that does not affect the stomach lining and has much stronger anti-cancer qualities but acknowledged NOSH aspirin is still an experimental drug and clinical use in humans is “years away.”

Still, other scientists say, the initial results are encouraging.

“It will be interesting to see how this particular compound progresses,” Kat Arney, of Cancer Research UK, told Britain’s The Daily Telegraph.


UPI - United Press International, Inc.

Since 1907, United Press International (UPI) has been a leading provider of critical information to media outlets, businesses, governments and researchers worldwide.

Facebook Conversations

Join the Discussion:
View Comments to “‘Super’ Aspirin Could Combat Cancers”

Comment Policy: We encourage an open discussion with a wide range of viewpoints, even extreme ones, but we will not tolerate racism, profanity or slanderous comments toward the author(s) or comment participants. Make your case passionately, but civilly. Please don't stoop to name calling. We use filters for spam protection. If your comment does not appear, it is likely because it violates the above policy or contains links or language typical of spam. We reserve the right to remove comments at our discretion.

Is there news related to personal liberty happening in your area? Contact us at


Sign Up For Personal Liberty Digest™!

PL Badge

Welcome to,
America's #1 Source for Libertarian News!

To join our group of freedom-loving individuals and to get alerts as well as late-breaking conservative news from Personal Liberty Digest™...

Privacy PolicyYou can opt out at any time. We protect your information like a mother hen. We will not sell or rent your email address to anyone for any reason.